Vascular Trial Associated Registry Pilot

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The purpose of this investigator-initiated, multicenter, open label, randomized trial is to evaluate 1 month vs. 6 months of dual antiplatelet therapy (DAPT) in patients undergoing lower extremity endovascular revascularization. We hypothesize that extending dual antiplatelet therapy (DAPT) to six months, compared to one month, will improve patency rates of target vessels following peripheral vascular intervention (PVI) without significantly increasing complications, particularly bleeding events.
Epistemonikos ID: d56312c268b82690ed017f12d0fe57d2ab1701d3
First added on: Jul 22, 2025